U.S. flag

An official website of the United States government

NM_002437.5(MPV17):c.106C>T (p.Gln36Ter) AND Charcot-Marie-Tooth disease, axonal, type 2EE

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 22, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003320355.3

Allele description [Variation Report for NM_002437.5(MPV17):c.106C>T (p.Gln36Ter)]

NM_002437.5(MPV17):c.106C>T (p.Gln36Ter)

Gene:
MPV17:mitochondrial inner membrane protein MPV17 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p23.3
Genomic location:
Preferred name:
NM_002437.5(MPV17):c.106C>T (p.Gln36Ter)
HGVS:
  • NC_000002.12:g.27313074G>A
  • NG_008075.1:g.14491C>T
  • NG_033055.1:g.190C>T
  • NM_002437.5:c.106C>TMANE SELECT
  • NP_002428.1:p.Gln36Ter
  • NC_000002.11:g.27535941G>A
  • NM_002437.4:c.106C>T
  • c.106C>T
  • p.Q36X
Protein change:
Q36*
Links:
dbSNP: rs754051090
NCBI 1000 Genomes Browser:
rs754051090
Molecular consequence:
  • NM_002437.5:c.106C>T - nonsense - [Sequence Ontology: SO:0001587]
Functional consequence:
protein truncation [Variation Ontology: 0015]

Condition(s)

Name:
Charcot-Marie-Tooth disease, axonal, type 2EE
Synonyms:
CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2EE
Identifiers:
MONDO: MONDO:0032728; MedGen: C5193076; OMIM: 618400

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003930386Neurogenomics Lab, Neuroscience Institute, University Of Cape Town
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(May 22, 2024)
germlineresearch

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes44not providednot providednot providedresearch

Citations

PubMed

The mutational profile in a South African cohort with inherited neuropathies and spastic paraplegia.

Mahungu AC, Steyn E, Floudiotis N, Wilson LA, Vandrovcova J, Reilly MM, Record CJ, Benatar M, Wu G, Raga S, Wilmshurst JM, Naidu K, Hanna M, Nel M, Heckmann JM.

Front Neurol. 2023;14:1239725. doi: 10.3389/fneur.2023.1239725.

PubMed [citation]
PMID:
37712079
PMCID:
PMC10497947

Identification of a single MPV17 nonsense-associated altered splice variant in 24 South African infants with mitochondrial neurohepatopathy.

Meldau S, De Lacy RJ, Riordan GTM, Goddard EA, Pillay K, Fieggen KJ, Marais AD, Van der Watt GF.

Clin Genet. 2018 May;93(5):1093-1096. doi: 10.1111/cge.13208. Epub 2018 Mar 25.

PubMed [citation]
PMID:
29318572
See all PubMed Citations (4)

Details of each submission

From Neurogenomics Lab, Neuroscience Institute, University Of Cape Town, SCV003930386.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedresearch PubMed (4)

Description

All 4 probands carry a second heterozygous MPV17 VUS NP_002428.1:p.Arg125Trp (not confirmed in trans).

Description

PM2_supporting: this variant is absent from gnomAD v4.0 (adequate coverage >20X confirmed) while it has a MAF of 0.007 and 0.015 in two independent control samples from South Africa (PMID 29318572 and PMID 30782936 respectively). PVS1 not assigned as loss of gene function is not an established pathogenic mechanism for MPV17-related CMT2EE; the majority of MPV17 variants associated with CMT2EE are homozygous missense variants while the single reported homozygous non-frameshift deletion, p.Asp126_Tyr136del, removes <10% of the MPV17 protein. Sequencing funded by the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD): https://www.ucl.ac.uk/genomic-medicine-neuromuscular-diseases/.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided4not provided4not provided

Last Updated: Jun 2, 2024